GENIAL is a pioneering initiative targeting alcohol-related liver cancer (ALD-HCC). Our primary goal is to identify genetic and environmental factors contributing to ALD-HCC risk and unravel how their interactions drive alcohol-related liver carcinogenesis. By pinpointing individuals at risk, GENIAL will pave the way for innovative prevention strategies and potential chemopreventive targets to tackle this devastating disease. Moreover, GENIAL is dedicated to educating and empowering the entire EU community with vital knowledge for effective disease prevention and early detection.
Read more about the projectNetworking Session at the EASL Congress 2024
| GENIAL Speaker | Pierre Nahon |
| Session title | Networking Session: GENIAL |
| Room | Track Hub: Liver Tumours |
| Date and time | Thursday, 6 June, 10:00 – 10:30 CEST |
GENIAL Project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101096312